Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells

Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):2980.

Abstract

The article "Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells" by Y. Wang, Y.-R. Zhao, A.-Y. Zhang, J. Ma, Z.-Z. Wang, X. Zhang, published in Eur Rev Med Pharmacol Sci 2017; 21 (9): 2087-2097 has been withdrawn.

MeSH terms

  • Adult
  • Aged
  • Animals
  • Apoptosis / drug effects*
  • CASP8 and FADD-Like Apoptosis Regulating Protein / biosynthesis*
  • Carcinoma, Hepatocellular / metabolism
  • Caspase 3 / metabolism
  • Caspase 8 / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Female
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms / metabolism
  • Male
  • Middle Aged
  • Rats
  • TNF-Related Apoptosis-Inducing Ligand / pharmacology*

Substances

  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • TNF-Related Apoptosis-Inducing Ligand
  • Caspase 3
  • Caspase 8